Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker VRTX
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Charles F. Wagner Jr. Officer | VRTX Vertex Pharmaceuticals Incorporated | 15,286 | $8.4M | 10b5-1 | Nov 12, 2026 | — | Form 144 ↗ |
| Nov 6, 2026 | Kewalramani Reshma Officer, Director | VRTX Vertex Pharmaceuticals Incorporated | 11,866 | $6.3M | 10b5-1 | Nov 6, 2026 | Form 4 ↗ 4 days later · 11,866 shares | Form 144 ↗ |
| Aug 27, 2026 | Bruce I. Sachs Director | VRTX Vertex Pharmaceuticals Incorporated | 1,210 | $662.5K | — | Aug 27, 2026 | — | Form 144 ↗ |
| Jul 2, 2026 | Tatsis Ourania Officer | VRTX Vertex Pharmaceuticals Incorporated | 1,500 | $787.5K | 10b5-1 | Jul 2, 2026 | Form 4 ↗ 5 days later · 1,500 shares | Form 144 ↗ |
| Jul 2, 2026 | Duncan McKechnie Officer | VRTX Vertex Pharmaceuticals Incorporated | 1,541 | $799.8K | 10b5-1 | Jul 2, 2026 | Form 4 ↗ 5 days later · 1,541 shares | Form 144 ↗ |
| Jul 1, 2026 | Joy Liu Officer | VRTX Vertex Pharmaceuticals Incorporated | 828 | $416.2K | 10b5-1 | Jul 1, 2026 | Form 4 ↗ 5 days later · 828 shares | Form 144 ↗ |
| Jun 26, 2026 | Carmen Bozic Officer | VRTX Vertex Pharmaceuticals Incorporated | 596 | $287.6K | 10b5-1 | Jun 26, 2026 | Form 4 ↗ 4 days later · 596 shares | Form 144 ↗ |
| Jun 18, 2026 | Carmen Bozic Officer | VRTX Vertex Pharmaceuticals Incorporated | 1,020 | $471.4K | 10b5-1 | Jun 18, 2026 | Form 4 ↗ 5 days later · 1,020 shares | Form 144 ↗ |
| Jun 15, 2026 | Carmen Bozic Officer | VRTX Vertex Pharmaceuticals Incorporated | 4,062 | $1.8M | 10b5-1 | Jun 15, 2026 | Form 4 ↗ 2 days later · 4,062 shares | Form 144 ↗ |
| Jun 5, 2026 | Carmen Bozic Officer | VRTX Vertex Pharmaceuticals Incorporated | 1,745 | $785.3K | 10b5-1 | Jun 5, 2026 | Form 4 ↗ 4 days later · 1,745 shares | Form 144 ↗ |
| Jun 1, 2026 | Joy Liu Officer | VRTX Vertex Pharmaceuticals Incorporated | 828 | $364.2K | 10b5-1 | Jun 1, 2026 | Form 4 ↗ 2 days later · 828 shares | Form 144 ↗ |
| May 29, 2026 | Carmen Bozic Officer | VRTX Vertex Pharmaceuticals Incorporated | 1,974 | $888.3K | 10b5-1 | May 29, 2026 | Form 4 ↗ 4 days later · 1,974 shares | Form 144 ↗ |
| May 15, 2026 | Carmen Bozic Officer | VRTX Vertex Pharmaceuticals Incorporated | 1,354 | $614.0K | 10b5-1 | May 15, 2026 | Form 4 ↗ 4 days later · 1,354 shares | Form 144 ↗ |
| May 15, 2026 | Mark E. Bunnage Officer | VRTX Vertex Pharmaceuticals Incorporated | 33 | $15.0K | 10b5-1 | May 15, 2026 | Form 4 ↗ 4 days later · 33 shares | Form 144 ↗ |
| May 12, 2026 | Carmen Bozic Officer | VRTX Vertex Pharmaceuticals Incorporated | 6,988 | $3.1M | 10b5-1 | May 12, 2026 | Form 4 ↗ 2 days later · 6,988 shares | Form 144 ↗ |
| May 6, 2026 | Jonathan Biller Officer | VRTX Vertex Pharmaceuticals Incorporated | 5,193 | $2.2M | — | May 6, 2026 | — | Form 144 ↗ |
| May 4, 2026 | Sangeeta N. Bhatia Director | VRTX Vertex Pharmaceuticals Incorporated | 318 | $134.7K | 10b5-1 | May 4, 2026 | Form 4 ↗ 1 day later · 318 shares | Form 144 ↗ |
| May 1, 2026 | Joy Liu Officer | VRTX Vertex Pharmaceuticals Incorporated | 1,104 | $469.2K | 10b5-1 | May 1, 2026 | Form 4 ↗ 4 days later · 1,104 shares | Form 144 ↗ |
| Apr 1, 2026 | Joy Liu Officer | VRTX Vertex Pharmaceuticals Incorporated | 978 | $439.3K | 10b5-1 | Apr 1, 2026 | Form 4 ↗ 2 days later · 978 shares | Form 144 ↗ |
| Mar 27, 2026 | Carmen Bozic Officer | VRTX Vertex Pharmaceuticals Incorporated | 2,329 | $1.1M | 10b5-1 | Mar 27, 2026 | Form 4 ↗ 4 days later · 2,329 shares | Form 144 ↗ |
| Mar 13, 2026 | Carmen Bozic Officer | VRTX Vertex Pharmaceuticals Incorporated | 2,329 | $1.1M | 10b5-1 | Mar 13, 2026 | Form 4 ↗ 4 days later · 2,329 shares | Form 144 ↗ |
| Mar 11, 2026 | Duncan McKechnie Officer | VRTX Vertex Pharmaceuticals Incorporated | 2,633 | $1.3M | 10b5-1 | Mar 11, 2026 | Form 4 ↗ 2 days later · 2,633 shares | Form 144 ↗ |
| Mar 4, 2026 | Duncan McKechnie Officer | VRTX Vertex Pharmaceuticals Incorporated | 2,437 | $1.2M | 10b5-1 | Mar 4, 2026 | Form 4 ↗ 2 days later · 2,437 shares | Form 144 ↗ |
| Mar 2, 2026 | Joy Liu Officer | VRTX Vertex Pharmaceuticals Incorporated | 892 | $442.4K | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 2 days later · 892 shares | Form 144 ↗ |
| Feb 27, 2026 | Kewalramani Reshma Officer, Director | VRTX Vertex Pharmaceuticals Incorporated | 40,000 | $19.7M | 10b5-1 | Feb 27, 2026 | Form 4 ↗ 4 days later · 40,000 shares | Form 144 ↗ |
| Feb 27, 2026 | Carmen Bozic Officer | VRTX Vertex Pharmaceuticals Incorporated | 2,329 | $1.1M | 10b5-1 | Feb 27, 2026 | Form 4 ↗ 4 days later · 2,329 shares | Form 144 ↗ |
| Feb 25, 2026 | Duncan McKechnie Officer | VRTX Vertex Pharmaceuticals Incorporated | 4,910 | $2.4M | 10b5-1 | Feb 25, 2026 | Form 4 ↗ 1 day later · 4,910 shares | Form 144 ↗ |
| Feb 25, 2026 | Tatsis Ourania Officer | VRTX Vertex Pharmaceuticals Incorporated | 260 | $126.5K | 10b5-1 | Feb 25, 2026 | Form 4 ↗ 1 day later · 260 shares | Form 144 ↗ |
| Feb 25, 2026 | Mark E. Bunnage Officer | VRTX Vertex Pharmaceuticals Incorporated | 620 | $301.5K | 10b5-1 | Feb 25, 2026 | Form 4 ↗ 1 day later · 620 shares | Form 144 ↗ |
| Feb 25, 2026 | Atkinson Edward Morrow III Officer | VRTX Vertex Pharmaceuticals Incorporated | 668 | $324.9K | 10b5-1 | Feb 25, 2026 | Form 4 ↗ 1 day later · 668 shares | Form 144 ↗ |
| Feb 25, 2026 | Amit Sachdev Officer | VRTX Vertex Pharmaceuticals Incorporated | 1,846 | $897.8K | 10b5-1 | Feb 25, 2026 | Form 4 ↗ 1 day later · 1,846 shares | Form 144 ↗ |
| Feb 25, 2026 | Jonathan Biller Officer | VRTX Vertex Pharmaceuticals Incorporated | 945 | $459.6K | 10b5-1 | Feb 25, 2026 | Form 4 ↗ 1 day later · 945 shares | Form 144 ↗ |
| Feb 19, 2026 | Amit Sachdev Officer | VRTX Vertex Pharmaceuticals Incorporated | 58,613 | $27.5M | 10b5-1 | Feb 19, 2026 | Form 4 ↗ 4 days later · 58,613 shares | Form 144 ↗ |
| Feb 18, 2026 | Tatsis Ourania Officer | VRTX Vertex Pharmaceuticals Incorporated | 368 | $174.3K | 10b5-1 | Feb 18, 2026 | Form 4 ↗ 1 day later · 977 shares | Form 144 ↗ |
| Feb 18, 2026 | Jonathan Biller Officer | VRTX Vertex Pharmaceuticals Incorporated | 1,244 | $589.3K | 10b5-1 | Feb 18, 2026 | Form 4 ↗ 1 day later · 3,720 shares | Form 144 ↗ |
| Feb 18, 2026 | Mark E. Bunnage Officer | VRTX Vertex Pharmaceuticals Incorporated | 1,182 | $559.9K | 10b5-1 | Feb 18, 2026 | Form 4 ↗ 1 day later · 3,619 shares | Form 144 ↗ |
| Feb 18, 2026 | Atkinson Edward Morrow III Officer | VRTX Vertex Pharmaceuticals Incorporated | 817 | $387.0K | 10b5-1 | Feb 18, 2026 | Form 4 ↗ 1 day later · 2,848 shares | Form 144 ↗ |
| Feb 17, 2026 | Mark E. Bunnage Officer | VRTX Vertex Pharmaceuticals Incorporated | 2,437 | $1.2M | 10b5-1 | Feb 17, 2026 | Form 4 ↗ 2 days later · 3,619 shares | Form 144 ↗ |
| Feb 17, 2026 | Tatsis Ourania Officer | VRTX Vertex Pharmaceuticals Incorporated | 609 | $298.1K | 10b5-1 | Feb 17, 2026 | Form 4 ↗ 2 days later · 977 shares | Form 144 ↗ |
| Feb 17, 2026 | Jonathan Biller Officer | VRTX Vertex Pharmaceuticals Incorporated | 2,476 | $1.2M | 10b5-1 | Feb 17, 2026 | Form 4 ↗ 2 days later · 3,720 shares | Form 144 ↗ |
| Feb 17, 2026 | Atkinson Edward Morrow III Officer | VRTX Vertex Pharmaceuticals Incorporated | 2,031 | $994.1K | 10b5-1 | Feb 17, 2026 | Form 4 ↗ 2 days later · 2,848 shares | Form 144 ↗ |
| Feb 13, 2026 | Jonathan Biller Officer | VRTX Vertex Pharmaceuticals Incorporated | 988 | $493.0K | 10b5-1 | Feb 13, 2026 | Form 4 ↗ 5 days later · 988 shares | Form 144 ↗ |
| Feb 13, 2026 | Sangeeta N. Bhatia Director | VRTX Vertex Pharmaceuticals Incorporated | 266 | $133.0K | 10b5-1 | Feb 13, 2026 | Form 4 ↗ 5 days later · 266 shares | Form 144 ↗ |
| Feb 13, 2026 | Tatsis Ourania Officer | VRTX Vertex Pharmaceuticals Incorporated | 1,500 | $750.0K | 10b5-1 | Feb 13, 2026 | Form 4 ↗ 5 days later · 1,500 shares | Form 144 ↗ |
| Feb 11, 2026 | Jonathan Biller Officer | VRTX Vertex Pharmaceuticals Incorporated | 1,925 | $886.3K | 10b5-1 | Feb 11, 2026 | Form 4 ↗ 1 day later · 1,925 shares | Form 144 ↗ |
| Feb 11, 2026 | Atkinson Edward Morrow III Officer | VRTX Vertex Pharmaceuticals Incorporated | 1,751 | $806.2K | 10b5-1 | Feb 11, 2026 | Form 4 ↗ 1 day later · 1,751 shares | Form 144 ↗ |
| Feb 11, 2026 | Mark E. Bunnage Officer | VRTX Vertex Pharmaceuticals Incorporated | 2,021 | $930.5K | 10b5-1 | Feb 11, 2026 | Form 4 ↗ 1 day later · 2,021 shares | Form 144 ↗ |
| Feb 11, 2026 | Tatsis Ourania Officer | VRTX Vertex Pharmaceuticals Incorporated | 466 | $214.6K | 10b5-1 | Feb 11, 2026 | Form 4 ↗ 1 day later · 466 shares | Form 144 ↗ |
| Jan 7, 2026 | Tatsis Ourania Officer | VRTX Vertex Pharmaceuticals Incorporated | 4,500 | $2.1M | 10b5-1 | Jan 7, 2026 | Form 4 ↗ 2 days later · 4,500 shares | Form 144 ↗ |
| Jan 6, 2026 | Charles F. Wagner Jr. Officer | VRTX Vertex Pharmaceuticals Incorporated | 9,532 | $4.4M | 10b5-1 | Jan 6, 2026 | Form 4 ↗ 2 days later · 9,532 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:50 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances